{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T05:33:09Z","timestamp":1733895189715,"version":"3.30.1"},"reference-count":33,"publisher":"Wiley","issue":"12","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd014439","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T11:51:10Z","timestamp":1733831470000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatments for RYR1-related disorders"],"prefix":"10.1002","volume":"2024","author":[{"given":"Sharika","family":"Raga","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology; University of Cape Town; Cape Town South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicol","family":"Voermans","sequence":"additional","affiliation":[{"name":"Neurology; Radboud University Medical Center; Nijmegen Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Perez-Neri","sequence":"additional","affiliation":[{"name":"Evidence Synthesis Unit; National Institute of Rehabilitation Luis Guillermo Ibarra Ibarra; Mexico City Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jim","family":"Dowling","sequence":"additional","affiliation":[{"name":"Division of Neurology; The Hospital for Sick Children, University of Toronto; Toronto Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Jungbluth","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology; Neuromuscular Service, Evelina\u2019s Children Hospital, Guy\u2019s & St. Thomas\u2019 Hospital NHS Foundation Trust; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Baranello","sequence":"additional","affiliation":[{"name":"Developmental Neurosciences Department; UCL GOS Institute of Child Health; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Servais","sequence":"additional","affiliation":[{"name":"Department of Paediatrics; MDUK Oxford Neuromuscular Centre and NIHR Oxford Biomedical Research Centre, University of Oxford; Oxford UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Tillema","sequence":"additional","affiliation":[{"name":"Medical Library; Radboud University; Nijmegen Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Wilmshurst","sequence":"additional","affiliation":[{"name":"Department of Paediatric Neurology; University of Cape Town; Cape Town South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,12,10]]},"reference":[{"key":"10.1002\/14651858.CD014439-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"761636","DOI":"10.3389\/fneur.2021.761636","article-title":"A systematic review and meta-analysis of the prevalence of congenital myopathy","volume":"12","author":"Huang","year":"2021","journal-title":"Frontiers in Neurology"},{"key":"10.1002\/14651858.CD014439-BIB0002|cit2","unstructured":"Kruijt N Wijma J Identification of a possible genetic background in patients with rhabdomyolysis due to neuroleptic malignant syndrome, serotonin syndrome and MDMA-related hyperthermia https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=115828 2018"},{"key":"10.1002\/14651858.CD014439-BIB0003|cit3","unstructured":"Larach MG Belani KG Brandom BW Capacchione J Herlich A Housey S Evidence to inform a recommendation on dantrolene availability for the treatment of malignant hyperthermia in anesthetizing locations https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=64696 2017"},{"issue":"Pt 4","key":"10.1002\/14651858.CD014439-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/brain\/aws036","article-title":"Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy","volume":"135","author":"Dowling","year":"2012","journal-title":"Brain"},{"issue":"2","key":"10.1002\/14651858.CD014439-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nm.2598","article-title":"AICAR prevents heat-induced sudden death in RyR1 mutant mice independent of AMPK activation","volume":"18","author":"Lanner","year":"2012","journal-title":"Nature Medicine"},{"issue":"7","key":"10.1002\/14651858.CD014439-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1089\/hum.2013.052","article-title":"Exon skipping as a therapeutic strategy applied to an RYR1 mutation with pseudo-exon inclusion causing a severe core myopathy","volume":"24","author":"Rendu","year":"2013","journal-title":"Human Gene Therapy"},{"issue":"3","key":"10.1002\/14651858.CD014439-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1177\/0883073812436605","article-title":"Consensus statement on standard of care for congenital myopathies","volume":"27","author":"Wang","year":"2011","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD014439-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jclinepi.2021.11.026","article-title":"GRADE guidance 24 optimizing the integration of randomized and non-randomized studies of interventions in evidence syntheses and health guidelines","volume":"142","author":"Cuello-Garcia","year":"2022","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014439-BIB0009|cit9","unstructured":"Higgins JPT Eldridge S Chapter 23: Including variants on randomized trials. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.2 (updated February 2021). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"issue":"12","key":"10.1002\/14651858.CD014439-BIB0010|cit10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013807","article-title":"Early surgical treatment versus observational management for cervical intraepithelial neoplasia 2 (CIN2)","author":"Rizzuto","year":"2020","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD014439-BIB0011|cit11","unstructured":"Reeves BC Deeks JJ Higgins JPT Shea B Tugwell P Wells GA Chapter 24: Including non-randomized studies on intervention effects. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.5. Cochrane, 2024 Available from www.training.cochrane.org\/handbook"},{"issue":"5","key":"10.1002\/14651858.CD014439-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genetics in Medicine"},{"key":"10.1002\/14651858.CD014439-BIB0013|cit13","unstructured":"McKenzie JE Brennan SE Ryan RE Thomson HJ Johnston RV Thomas J Chapter 3: Defining the criteria for including studies and how they will be grouped for the synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.4 (updated August 2023). Cochrane, 2023 Available from training.cochrane.org\/handbook"},{"issue":"10","key":"10.1002\/14651858.CD014439-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1212\/wnl.38.10.1639","article-title":"Treatment of Guillain-Barr\u00e9 syndrome with high-dose gammaglobulin","volume":"38","author":"Kleyweg","year":"1988","journal-title":"Neurology"},{"issue":"12","key":"10.1002\/14651858.CD014439-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1177\/0883073811420294","article-title":"Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III","volume":"26","author":"Glanzman","year":"2011","journal-title":"Journal of Child Neurology"},{"key":"10.1002\/14651858.CD014439-BIB0016|cit16","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Marshall C Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014439-BIB0017|cit17","unstructured":"Covidence Veritas Health Innovation 2023"},{"issue":"7","key":"10.1002\/14651858.CD014439-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLOS Medicine"},{"key":"10.1002\/14651858.CD014439-BIB0019|cit19","unstructured":"Higgins JPT Savovi\u0107 J Page MJ Elbers RG Sterne JAC Chapter 8: Assessing risk of bias in a randomized trial. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014439-BIB0020|cit20","first-page":"l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD014439-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014439-BIB0022|cit22","unstructured":"Higgins JP Li T Deeks JJ Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014439-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","article-title":"Extracting summary statistics to perform meta-analysis of the published literature for survival endpoints","volume":"17","author":"Parmar","year":"1998","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD014439-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"issue":"7109","key":"10.1002\/14651858.CD014439-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD014439-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"k4817","DOI":"10.1136\/bmj.k4817","article-title":"When continuous outcomes are measured using different scales: guide for meta-analysis and interpretation","volume":"364","author":"Murad","year":"2019","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014439-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"l6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD014439-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"10.1002\/14651858.CD014439-BIB0029|cit29","unstructured":"Deeks JJ Higgins JP Altman DG Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD014439-BIB0030|cit30","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"key":"10.1002\/14651858.CD014439-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jclinepi.2013.08.005","article-title":"Applying an equity lens to interventions: using PROGRESS ensures consideration of socially stratifying factors to illuminate inequities in health","volume":"67","author":"O'Neill","year":"2014","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD014439-BIB0032|cit32","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2022"},{"key":"10.1002\/14651858.CD014439-BIB0033|cit33","unstructured":"Sch\u00fcnemann HJ Higgins JP Vist GE Glasziou P Akl EA Skoetz N Chapter 14: Completing \u2018Summary of findings\u2019 tables and grading the certainty of the evidence. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022 Available from www.training.cochrane.org\/handbook"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T11:51:22Z","timestamp":1733831482000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD014439"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,10]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd014439","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,10]]}}}